Circulating Tumor DNA Analysis Market: Trends and Future Outlook
The Liquid Biopsy Market is revolutionizing modern healthcare by enabling advanced diagnostic techniques such as circulating tumor DNA analysis, which plays a pivotal role in precision medicine. With a market size of USD 11.91 billion in 2024 and an expected value of USD 36.59 billion by 2034, growing at a CAGR of 11.9%, the adoption of liquid biopsy tests is accelerating globally. Liquid...
0 Commentarii 0 Distribuiri 4 Views 0 previzualizare